rs111033388

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 3P and 16B. PM4PP3BP6_Very_StrongBS1BS2

The NM_000260.4(MYO7A):​c.6614_6634dupTGAGCAAACAGCGGGGCTCCA​(p.Met2205_Ser2211dup) variant causes a disruptive inframe insertion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00126 in 1,589,124 control chromosomes in the GnomAD database, including 30 homozygotes. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. R2212R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0070 ( 19 hom., cov: 32)
Exomes 𝑓: 0.00065 ( 11 hom. )

Consequence

MYO7A
NM_000260.4 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 7.53

Publications

2 publications found
Variant links:
Genes affected
MYO7A (HGNC:7606): (myosin VIIA) This gene is a member of the myosin gene family. Myosins are mechanochemical proteins characterized by the presence of a motor domain, an actin-binding domain, a neck domain that interacts with other proteins, and a tail domain that serves as an anchor. This gene encodes an unconventional myosin with a very short tail. Defects in this gene are associated with the mouse shaker-1 phenotype and the human Usher syndrome 1B which are characterized by deafness, reduced vestibular function, and (in human) retinal degeneration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]
MYO7A Gene-Disease associations (from GenCC):
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive nonsyndromic hearing loss 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, G2P
  • Usher syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, PanelApp Australia
  • Usher syndrome type 1B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal dominant nonsyndromic hearing loss 11
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Usher syndrome type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

PM4
Nonframeshift variant in NON repetitive region in NM_000260.4.
PP3
No computational evidence supports a deleterious effect, but strongly conserved according to phyloP
BP6
Variant 11-77214658-G-GCCATGAGCAAACAGCGGGGCT is Benign according to our data. Variant chr11-77214658-G-GCCATGAGCAAACAGCGGGGCT is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 177815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00696 (1060/152304) while in subpopulation AFR AF = 0.0245 (1018/41538). AF 95% confidence interval is 0.0233. There are 19 homozygotes in GnomAd4. There are 488 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 19 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO7ANM_000260.4 linkc.6614_6634dupTGAGCAAACAGCGGGGCTCCA p.Met2205_Ser2211dup disruptive_inframe_insertion Exon 49 of 49 ENST00000409709.9 NP_000251.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO7AENST00000409709.9 linkc.6614_6634dupTGAGCAAACAGCGGGGCTCCA p.Met2205_Ser2211dup disruptive_inframe_insertion Exon 49 of 49 1 NM_000260.4 ENSP00000386331.3
MYO7AENST00000458637.6 linkc.6494_6514dupTGAGCAAACAGCGGGGCTCCA p.Met2165_Ser2171dup disruptive_inframe_insertion Exon 49 of 49 1 ENSP00000392185.2
MYO7AENST00000409619.6 linkc.6467_6487dupTGAGCAAACAGCGGGGCTCCA p.Met2156_Ser2162dup disruptive_inframe_insertion Exon 50 of 50 1 ENSP00000386635.2
MYO7AENST00000458169.2 linkc.4040_4060dupTGAGCAAACAGCGGGGCTCCA p.Met1347_Ser1353dup disruptive_inframe_insertion Exon 29 of 29 1 ENSP00000417017.2
MYO7AENST00000670577.1 linkn.*1186_*1206dupTGAGCAAACAGCGGGGCTCCA non_coding_transcript_exon_variant Exon 32 of 32 ENSP00000499323.1
MYO7AENST00000670577.1 linkn.*1186_*1206dupTGAGCAAACAGCGGGGCTCCA 3_prime_UTR_variant Exon 32 of 32 ENSP00000499323.1

Frequencies

GnomAD3 genomes
AF:
0.00698
AC:
1062
AN:
152186
Hom.:
19
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0246
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00183
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00383
GnomAD2 exomes
AF:
0.00116
AC:
244
AN:
210546
AF XY:
0.000965
show subpopulations
Gnomad AFR exome
AF:
0.0170
Gnomad AMR exome
AF:
0.00103
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000428
Gnomad OTH exome
AF:
0.000557
GnomAD4 exome
AF:
0.000651
AC:
936
AN:
1436820
Hom.:
11
Cov.:
30
AF XY:
0.000563
AC XY:
401
AN XY:
711950
show subpopulations
African (AFR)
AF:
0.0240
AC:
790
AN:
32932
American (AMR)
AF:
0.00113
AC:
46
AN:
40812
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25668
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38550
South Asian (SAS)
AF:
0.0000244
AC:
2
AN:
81836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51806
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5744
European-Non Finnish (NFE)
AF:
0.0000127
AC:
14
AN:
1099876
Other (OTH)
AF:
0.00131
AC:
78
AN:
59596
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
43
87
130
174
217
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00696
AC:
1060
AN:
152304
Hom.:
19
Cov.:
32
AF XY:
0.00655
AC XY:
488
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.0245
AC:
1018
AN:
41538
American (AMR)
AF:
0.00183
AC:
28
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68042
Other (OTH)
AF:
0.00379
AC:
8
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
50
101
151
202
252
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00331
Hom.:
0

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Clinical Genetics, Academic Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

May 24, 2022
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria.

not specified Benign:2
Dec 21, 2015
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

c.6614_6634dup (p.Met2205_Ser221dup) in exon49 of MYO7A: This variant is not exp ected to have clinical significance because it has been identified in 2% (73/340 2) of African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac .broadinstitute.org; dbSNP rs111033388).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
7.5
Mutation Taster
=28/72
disease causing

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111033388; hg19: chr11-76925703; API